Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth‐promoting therapy in peripubertal growth delays: Results of a retrospective study among ENDO‐ERN centres. (15th October 2020)
- Record Type:
- Journal Article
- Title:
- Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth‐promoting therapy in peripubertal growth delays: Results of a retrospective study among ENDO‐ERN centres. (15th October 2020)
- Main Title:
- Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth‐promoting therapy in peripubertal growth delays: Results of a retrospective study among ENDO‐ERN centres
- Authors:
- Galazzi, Elena
Improda, Nicola
Cerbone, Manuela
Soranna, Davide
Moro, Mirella
Fatti, Letizia Maria
Zambon, Antonella
Bonomi, Marco
Salerno, Mariacarolina
Dattani, Mehul
Persani, Luca - Abstract:
- Abstract: Objectives: Sex steroids, administered as a priming before GH stimulation tests (GHST) to differentiate between growth hormone deficiency (GHD) and constitutional delay of growth and puberty (CDGP) or as growth‐promoting therapy using low‐dose sex steroids (LDSS) in CDGP, are much debated. We aimed to compare auxological outcomes of CDGP or GHD children undergoing primed or unprimed GHST and to evaluate LDSS treatment in CDGP. Design: Retrospective study among three paediatric University Hospitals in Italy and UK. Methods: 184 children (72 females) aged 12.4 ± 2.08 years underwent primed (/P + ) or unprimed (/P − ) GHST and were followed up until final height (FH). CDGP patients were untreated (CDG P − ) or received LDSS (CDGP + ). The cohort included 34 CDG P − /P +, 12 CDGP + /P +, 51 GHD/P +, 29 CDG P − /P −, 2 CDGP + /P − and 56 GHD/P − . FH standard deviation score (SDS), Δ SDS FH‐target height (TH) and degree of success (−1 ≤ Δ SDS FH‐SDS TH ≤ +1) were outcomes of interest. Results: GHD/P + had better FH‐SDS (−0.87 vs −1.49; P = .023) and ΔSDS FH‐TH (−0.35 vs −0.77; P = .002) than CDGP − /P + . Overall, GHD/P + showed the highest degree of success (90%, P = .006). Regardless of priming, both rhGH and LDSS improved degree of success compared to no treatment (89% and 86% vs 63%, P = .0009). GHD/P + showed a trend towards a higher proportion of permanent GHD compared to GHD/P ‐ (30.43% vs 15.09%; P = .067). Conclusion: In peripubertal children, primingAbstract: Objectives: Sex steroids, administered as a priming before GH stimulation tests (GHST) to differentiate between growth hormone deficiency (GHD) and constitutional delay of growth and puberty (CDGP) or as growth‐promoting therapy using low‐dose sex steroids (LDSS) in CDGP, are much debated. We aimed to compare auxological outcomes of CDGP or GHD children undergoing primed or unprimed GHST and to evaluate LDSS treatment in CDGP. Design: Retrospective study among three paediatric University Hospitals in Italy and UK. Methods: 184 children (72 females) aged 12.4 ± 2.08 years underwent primed (/P + ) or unprimed (/P − ) GHST and were followed up until final height (FH). CDGP patients were untreated (CDG P − ) or received LDSS (CDGP + ). The cohort included 34 CDG P − /P +, 12 CDGP + /P +, 51 GHD/P +, 29 CDG P − /P −, 2 CDGP + /P − and 56 GHD/P − . FH standard deviation score (SDS), Δ SDS FH‐target height (TH) and degree of success (−1 ≤ Δ SDS FH‐SDS TH ≤ +1) were outcomes of interest. Results: GHD/P + had better FH‐SDS (−0.87 vs −1.49; P = .023) and ΔSDS FH‐TH (−0.35 vs −0.77; P = .002) than CDGP − /P + . Overall, GHD/P + showed the highest degree of success (90%, P = .006). Regardless of priming, both rhGH and LDSS improved degree of success compared to no treatment (89% and 86% vs 63%, P = .0009). GHD/P + showed a trend towards a higher proportion of permanent GHD compared to GHD/P ‐ (30.43% vs 15.09%; P = .067). Conclusion: In peripubertal children, priming before GHST improves diagnostic accuracy of GHST for idiopathic GHD. LDSS treatment improves auxological outcomes in CDGP. … (more)
- Is Part Of:
- Clinical endocrinology. Volume 94:Number 2(2021)
- Journal:
- Clinical endocrinology
- Issue:
- Volume 94:Number 2(2021)
- Issue Display:
- Volume 94, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 94
- Issue:
- 2
- Issue Sort Value:
- 2021-0094-0002-0000
- Page Start:
- 219
- Page End:
- 228
- Publication Date:
- 2020-10-15
- Subjects:
- constitutional delay of growth and puberty -- final height -- idiopathic growth hormone deficiency -- puberty -- sex steroid priming -- short stature
Endocrinology -- Periodicals
616.4005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2265 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cen.14337 ↗
- Languages:
- English
- ISSNs:
- 0300-0664
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.278000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15702.xml